Edwards Lifesciences Corporation (BMV:EW)

Market Cap	805.07B
Revenue (ttm)	107.21B
Net Income (ttm)	78.22B
Shares Out	n/a
EPS (ttm)	132.33
PE Ratio	10.29
Forward PE	28.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,425
Open	1,879.60
Previous Close	1,372.00
Day's Range	1,865.58 - 1,892.98
52-Week Range	1,280.34 - 1,878.80
Beta	1.07
RSI	43.05
Earnings Date	Oct 24, 2025

About Edwards Lifesciences

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solution...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1958
• Employees: 15,800
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: EW

Financial Performance

In 2024, Edwards Lifesciences's revenue was $5.44 billion, an increase of 8.57% compared to the previous year's $5.01 billion. Earnings were $4.17 billion, an increase of 197.68%.

Financial numbers in USD